Strata Oncology is a precision oncology company dedicated to delivering the best possible treatment for each patient with cancer.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
07/28/2021 | Series A-4 | $5.08MM | $xx.xx | $561.3MM | Wellington Management, Cormorant Asset Management, Monashee Investment Management, Highside Capital Management, Pfizer Ventures, Merck Global Health Innovation Fund, Arboretum Ventures, Deerfield Management, Baird Capital, Renaissance Venture Capital | |
Price per Share
$xx.xx
Shares Outstanding
171,358
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Wellington Management, Cormorant Asset Management, Monashee Investment Management, Highside Capital Management, Pfizer Ventures, Merck Global Health Innovation Fund, Arboretum Ventures, Deerfield Management, Baird Capital, Renaissance Venture Capital
|
||||||
07/28/2021 | Series A-3 | $84.92MM | $xx.xx | $561.3MM | Wellington Management, Cormorant Asset Management, Monashee Investment Management, Highside Capital Management, Pfizer Ventures, Merck Global Health Innovation Fund, Arboretum Ventures, Deerfield Management, Baird Capital, Renaissance Venture Capital | |
Price per Share
$xx.xx
Shares Outstanding
2,434,429
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Wellington Management, Cormorant Asset Management, Monashee Investment Management, Highside Capital Management, Pfizer Ventures, Merck Global Health Innovation Fund, Arboretum Ventures, Deerfield Management, Baird Capital, Renaissance Venture Capital
|
||||||
05/01/2018 | Series A-2 | $26MM | $xx.xx | $86.53MM | Deerfield Management, Renaissance Venture Capital, Pfizer Ventures, Merck Global Health Innovation Fund, Baird Capital, Arboretum Ventures | |
Price per Share
$xx.xx
Shares Outstanding
3,938,877
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Deerfield Management, Renaissance Venture Capital, Pfizer Ventures, Merck Global Health Innovation Fund, Baird Capital, Arboretum Ventures
|
||||||
06/02/2016 | Series A-1 | $12.34MM | $xx.xx | $22.45MM | Arboretum Ventures, Baird Capital, Michigan eLab | |
Price per Share
$xx.xx
Shares Outstanding
4,579,011
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Arboretum Ventures, Baird Capital, Michigan eLab
|